Radiation oncologists underrecognized common symptoms of acute toxicity in more than half of patients, and more often in Black patients than white patients.
Clinicians will readily acknowledge that limited time with patients in a busy clinic often does not allow for a complete survey of all symptoms that may be affecting a given patient. This is true in all subspecialties caring for patients with breast cancer. The current analysis comparing patient-reported outcomes (PROs) with radiation oncologists' assessments of common symptoms of breast radiotherapy (pain, pruritis, edema, and fatigue) brings this issue to the fore.
Nearly 10,000 patients from across radiation oncology 29 practices were included, of whom 17% were Black and 80% were white. More than 50% of patients experienced acute toxicity related to radiation therapy that went underrecognized by physicians. Factors independently associate…
Reviewing Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)